Ignite Creation Date:
2024-05-05 @ 4:40 PM
Last Modification Date:
2024-10-26 @ 9:23 AM
Study NCT ID:
NCT00299000
Status:
COMPLETED
Last Update Posted:
2011-07-22
First Post:
2006-03-02
Brief Title:
A Phase 4 Two Dose Level Study of NaglazymeTM Galsulfase in Infants With MPS VI
Sponsor:
BioMarin Pharmaceutical
Organization:
BioMarin Pharmaceutical
Organization Data
Organization:
BioMarin Pharmaceutical
Class:
INDUSTRY
Study ID:
ASB-008
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
BioMarin Pharmaceutical
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Celeste Decker MD
Old Organization:
BioMarin Pharmaceutical Inc